Coronavirus live updates: South Korea closes most schools in Seoul area; first confirmed case of reinfection

Health, Fitness & Food

Scientists are expressing some doubts about the Food and Drug Administration’s emergency use authorization for convalescent plasma as a treatment for Covid-19 patients. In a Sunday news briefing, President Donald Trump touted the treatment as a “breakthrough.” Former FDA chief Dr. Scott Gottlieb told CNBC that while there was enough data to justify the authorization, the treatment is not a “home run.” 

The following data was compiled by Johns Hopkins University:

  • Global cases: More than 23.4 million
  • Global deaths: At least 809,300
  • U.S. cases: More than 5.7 million
  • U.S. deaths: At least 176,800

Products You May Like

Articles You May Like

It’s not entirely clear how the government will pay for Trump’s $200 Medicare cards
Fewer than 10% of Americans show signs of past coronavirus infection, study finds
Everyone thought Germany and Italy weren’t seeing a second wave of the coronavirus … now maybe they are
Trump’s coronavirus vaccine czar says he’s had ‘enough’ of Democratic calls for his firing over pharma stock holdings
Johnson & Johnson enters late-stage trial testing its coronavirus vaccine

Leave a Reply

Your email address will not be published. Required fields are marked *